This is a multi-national, phase II, parallel-arm, double-blind, placebo-controlled, two-arm study designed to assess the efficacy and safety of SIRT-Y90 followed by atezolizumab pl
-
Study number:
-
NCT05377034
-
Cohorts:
-
1
-
Study phase:
-
2
-
Overall status:
-
Not yet recruiting
-
Study type:
-
Local/Regional therapies, Immunotherapy, Targeted therapy